3 results match your criteria: "Centre d'Immunologie et des Maladies Infectieuses (CIMIParis)[Affiliation]"
SARS-CoV-2 infection fatality rate (IFR) doubles with every five years of age from childhood onward. Circulating autoantibodies neutralizing IFN-α, IFN-ω, and/or IFN-β are found in ~20% of deceased patients across age groups. In the general population, they are found in ~1% of individuals aged 20-70 years and in >4% of those >70 years old.
View Article and Find Full Text PDFImmune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study.
Front Immunol
June 2021
Sorbonne Université, Inserm, Centre d'Immunologie et des Maladies Infectieuses (CIMIParis), Paris, France.
Article Synopsis
- Researchers tested a new HIV vaccine called MVA-B to see how it affects the immune system when given in different ways: through the skin or in the muscle.
- They found that both ways were safe, but how the body responds to the vaccine was different depending on the route.
- Vaccination through the skin helped activate certain immune cells better, while muscle vaccination changed how the body processes immune signals.
Analysis of bacterial-surface-specific antibodies in body fluids using bacterial flow cytometry.
Nat Protoc
August 2016
Institute for Microbiology, ETH Zurich, Zurich, Switzerland.
Antibacterial antibody responses that target surfaces of live bacteria or secreted toxins are likely to be relevant in controlling bacterial pathogenesis. The ability to specifically quantify bacterial-surface-binding antibodies is therefore highly attractive as a quantitative correlate of immune protection. Here, binding of antibodies from various body fluids to pure-cultured live bacteria is made visible with fluorophore-conjugated secondary antibodies and measured by flow cytometry.
View Article and Find Full Text PDF